Report cover image

Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029

Publisher MarketsandMarkets
Published Mar 19, 2024
Length 597 Pages
SKU # MKMK18640260

Description

Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029



The cell expansion market is projected to reach USD 26.7 billion by 2029 from an estimated USD 14.3 billion in 2024, at a CAGR of 13.3% during the forecast period of 2024 to 2029. The growth of this market can be attributed to increasing prevalence of chronic diseases. The rising rate of chronic diseases such as cancer is propelling the need of cell based therapies such as cell & gene therapy, tissue engineering, and regenerative medicine. The rising deamd for innovative cell based therapies and novel therapeutics is propelling the need of cell expansion. This trend is expected to drive the growth of the cell expansion market in the coming years.

“The biopharmaceutical production segment accounted for the largest share of by application segment in 2023.”

In 2023, the biopharmaceutical production segment accounted for the largest share of by application segment in the global cell expansion market. Biopharmaceutical production include monoclonal antibody production, vaccine production, and other therapeutic protein production. The growing investments and fundings for the development of novel drug products and rising demand for biological therapies such as monoclonal antibosies, vaccines, and therapeutic proteins are promoting the growth of biopharmaceutical production in cell expansion market.

“The US has continued to dominate the cell expansion market during the forecast period of 2024-2029.”

The US dominated the cell expansion market in North America in 2023. The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Additionally, the US is home to some of the world’s leading academic research institutes, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutes conduct cutting-edge research in life sciences, including drug discovery and biotechnology, which involve adoption of cell expansion techniques, resulting to propel the market growth. Additionally, increasing fundings in the field of tissue engineering and regenerative medicine are also driving the growth of cell expansion market.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 60% and Demand Side 40%

By Designation: Managers - 55%, CXO & Directors - 20%, and Executives - 25%

By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Thermo Fisher Scientific Inc. (US)

Danaher Corporation (US)

Merck KGaA (Germany)

Sartorius AG (Germany)

Corning Incorporated (US)

Lonza (Switzerland)

Terumo Corporation (Japan)

Eppendorf SE (Germany)

FUJIFILM Corporation (Japan)

Bio-Techne (US)

Repligen Corporation (US)

Getinge AB (Sweden)

Miltenyi Biotec (Germany)

PerkinElmer Inc. (US)

STEMCELL Technologies (Canada)

PromoCell GmBHGmbH (Germany)

HiMedia Laboratories (India)

BD (US)

Takara Bio Inc. (Japan)

Shanghai Duoning Biotechnology Co., Ltd. (Japan)

REPROCELL Inc. (Japan)

PBS Biotech, Inc. (US)

ACROBiosystems (US)

Solida Biotech GmBH (Germany)

Beijing CytoNiche Biotechnology Co., Ltd. (China)

Neuromics (US)

Bionet (Spain)

Cellexus (UK)

Research Coverage:

This research report categorizes the cell expansion market by product (consumables and equipment), by cell type (human cells, animal cells, and other cell types), by application (biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell expansion market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. Also, it include new product launches, collaborations and acquisitions, and recent developments associated with the cell expansion market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell expansion market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (increasing prevalence of chronic diseases, rising investments and fundings in cell based research, and growing strategic alliances for the development of biotechnology industry), restraints (high cost of cell based therapies and ethical concern regarding cell biology), opportunities (growing opportunities in emerging economies, advances in 3D cell expansion technology), and Challenges (concern regarding supply chain and logistics) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched products of the cell expansion market

Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market

Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), Corning Incorporated (US), Lonza (Switzerland), Terumo Corporation (Japan), Eppendorf SE (Germany), FUJIFILM Corporation (Japan), Bio-Techne (US), Repligen Corporation (US), Getinge AB (Sweden), Miltenyi Biotec (Germany), PerkinElmer Inc. (US), STEMCELL Technologies (Canada), PromoCell GmBH (Germany), HiMedia Laboratories (India), BD (US), Takara Bio Inc. (Japan), Shanghai Duoning Biotechnology Co., Ltd. (Japan), REPROCELL Inc. (Japan), PBS Biotech, Inc. (US), ACROBiosystems (US), Solida Biotech GmBH (Germany), Beijing CytoNiche Biotechnology Co., Ltd. (China), Neuromics (US), Bionet (Spain), and Cellexus (UK), among others in the market

Table of Contents

597 Pages
    • STUDY OBJECTIVES
    • MARKET DEFINITION
    • STUDY SCOPE
    • YEARS CONSIDERED
    • CURRENCY
    • STAKEHOLDERS
    • LIMITATIONS
    • SUMMARY OF CHANGES
    • RECESSION IMPACT
    • RESEARCH DATA
    • MARKET ESTIMATION METHODOLOGY
    • BOTTOM-UP APPROACH
    • INSIGHTS FROM PRIMARY EXPERTS
    • TOP-DOWN APPROACH
    • GROWTH FORECAST
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
    • MARKET FORECAST
    • RISK ANALYSIS
    • RECESSION IMPACT ANALYSIS
  • EXECUTIVE SUMMARY
    • CELL EXPANSION MARKET OVERVIEW
    • ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT & COUNTRY (2023)
    • CELL EXPANSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • CELL EXPANSION MARKET SHARE, BY END USER, 2023
    • INTRODUCTION
    • MARKET DYNAMICS
    • TECHNOLOGY ANALYSIS
    • TRADE DATA
    • SUPPLY CHAIN ANALYSIS
    • VALUE CHAIN ANALYSIS
    • PRICING ANALYSIS
    • ECOSYSTEM ANALYSIS
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
    • PATENT ANALYSIS
    • KEY CONFERENCES AND EVENTS
    • REGULATORY LANDSCAPE
    • PORTER’S FIVE FORCES ANALYSIS
    • KEY STAKEHOLDERS AND BUYING CRITERIA
    • INVESTMENT/FUNDING ACTIVITIES
    • INTRODUCTION
    • CONSUMABLES
    • EQUIPMENT
    • INTRODUCTION
    • HUMAN CELLS
    • ANIMAL CELLS
    • OTHER CELL TYPES
    • INTRODUCTION
    • BIOPHARMACEUTICAL PRODUCTION
    • TISSUE ENGINEERING & REGENERATIVE MEDICINE
    • DRUG SCREENING & DEVELOPMENT
    • OTHER APPLICATIONS
    • INTRODUCTION
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • RESEARCH & ACADEMIC INSTITUTES
    • HOSPITALS & DIAGNOSTIC LABORATORIES
    • OTHER END USERS
    • INTRODUCTION
    • NORTH AMERICA
    • EUROPE
    • ASIA PACIFIC
    • LATIN AMERICA
    • MIDDLE EAST
    • AFRICA
    • OVERVIEW
    • STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
    • REVENUE SHARE ANALYSIS
    • MARKET SHARE ANALYSIS
    • BRAND/PRODUCT COMPARATIVE ANALYSIS
    • COMPANY EVALUATION MATRIX: KEY PLAYERS
    • COMPANY FOOTPRINT: KEY PLAYERS
    • COMPANY EVALUATION MATRIX: STARTUPS/SMES
    • VALUATION AND FINANCIAL METRICS OF CELL EXPANSION VENDORS
    • COMPETITIVE SCENARIO
    • INTRODUCTION
    • KEY PLAYERS
    • OTHER PLAYERS
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us